By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > Announcement: Skin Biopsy PCR Test Accelerates Diagnosis of Tattoo-Associated Toxic Shock Syndrome

Announcement: Skin Biopsy PCR Test Accelerates Diagnosis of Tattoo-Associated Toxic Shock Syndrome

GMJ
Last updated: 07/08/2026 11:29
By
Prof. Giorgi Pkhakadze
Share
0 Min Read
Medical illustration of staphylococcal toxic shock syndrome progression and PCR diagnostic timeline
A new PCR-based diagnostic test on skin biopsies enables rapid confirmation of tattoo-associated staphylococcal toxic shock syndrome within 24–48 hours—potentially 24–48 hours faster than conventional culture methods. This acceleration addresses a critical clinical need in a life-threatening post-tattoo infection. — Photo by cottonbro studio on Pexels (Pexels License)
SHARE
1 min read|54 words

Researchers have developed a PCR-based skin biopsy test that diagnoses tattoo-associated staphylococcal toxic shock syndrome within 24–48 hours—potentially twice as fast as conventional culture methods. This breakthrough could accelerate treatment and improve outcomes in a rare but life-threatening post-tattoo infection. Read the full analysis from GMJ News.

Read the full article on GMJ Newsroom →

Was this article helpful?

GMJ Brief · Announcement

📰 Read the full article: Skin Biopsy PCR Test Accelerates Diagnosis of Tattoo-Associated Toxic Shock Syndrome →

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
What makes prostate cancer aggressive? Biology, genetics, and clinical grading explained

Prostate cancer aggressiveness is determined by histological grade (Gleason score), genetic mutations…

UK childhood vaccination coverage holds steady at high levels, latest quarterly data shows

The UK's Cover of Vaccination Evaluated Rapidly (COVER) programme reports sustained high…

EMA Launches Email Notifications for Clinical Trial Information System

The European Medicines Agency has rolled out email notification subscriptions in CTIS,…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Medical researcher analyzing genetic test results for breast cancer treatment decisions

Genetic Test Opens Door to Chemotherapy-Free Treatment for Thousands of Breast Cancer Patients

By
Prof. Giorgi Pkhakadze
16/06/2026
Dexcom G7 continuous glucose monitoring sensor with FDA safety alert overlay

Defective Glucose Sensors Diverted: Scale of Dexcom Manufacturing Breach Revealed

By
Prof. Giorgi Pkhakadze
21/06/2026
UK pharmaceutical manufacturing facility with MHRA regulatory approval documentation

What UK Pharmaceutical Licensing Expansion Means for Medicine Access and Healthcare Security

By
Prof. Giorgi Pkhakadze
12/07/2026
Illustration showing plant-rich diet promoting healthy gut bacteria versus processed food diet with inflammatory microbiota shifts

Trillions of Microbial Partners: How Diet Controls Your Gut Ecosystem

By
Prof. Giorgi Pkhakadze
08/08/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up